Skip to content

Retrospective Performance Evaluation of a Headache Diagnostic Program for Supporting the Diagnosis of Primary Headache

Retrospective Performance Evaluation of a Headache Diagnostic Program for Supporting the Diagnosis of Primary Headache

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
JPRN
Registry ID
JPRN-jRCT1032250289
Enrollment
327
Registered
2025-08-13
Start date
2025-08-13
Completion date
Unknown
Last updated
2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

headache disorder

Interventions

None listed

Sponsors

Kawata Yumi
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: The data are registered in the observational study (jRCT1030240662).

Exclusion criteria

Exclusion criteria: none

Design outcomes

Primary

MeasureTime frame
Based on the confirmed diagnosis by a headache specialist as the reference standard, the lower bound of the 95% confidence interval for the sensitivity of this product in both Class 1 and Class 2 surpasses the pre-defined performance target.

Secondary

MeasureTime frame
1. Overall accuracy and area under the curve (AUC) of the product across all classes, using the confirmed diagnosis by a headache specialist as the reference standard. 2. Specificity, accuracy, and AUC of the product for Class 1 and Class 2, using the confirmed diagnosis by a headache specialist as the reference standard. 3. Sensitivity, specificity, accuracy, and AUC of the product for Class 3 and Class X, using the confirmed diagnosis by a headache specialist as the reference standard. 4. Sensitivity, specificity, and accuracy of the product for Class 3+X (Class 3 or Class X), using the confirmed diagnosis by a headache specialist as the reference standard.

Contacts

Public ContactYuya Karino

Hedgehog MedTech, Inc.

yuya.karino@h-medtech.com+81-80-5430-2115

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026